Cytarabine hydrochloride for injection is a sterile lyophilized product of cytarabine hydrochloride. Cytarabine hydrochloride is a cytotoxic agent used for hematological malignancies and lymphomas. CD BioGlyco provides reliable cytarabine hydrochloride for injection analysis service. Our mature experience and expertise in Pharmaceutical Analysis enable us to deliver high-quality solutions to our clients. Moreover, we provide professional Biological Evaluation and Pharmaceutical Excipient Analysis services.
Fig.1 Schematic diagram of cytarabine hydrochloride for injection service. (CD BioGlyco)
Technology: Scanning electron microscopy, Spectrophotometer, HPLC
Journal: Journal of Biomedical Nanotechnology
Published: 2007
IF: 2.9
Results: In this work, researchers synthesized and characterized cytarabine hydrochloride nanoparticles. The in vitro drug release results showed that cytarabine hydrochloride nanoparticles effectively prolonged the lifespan of mice. Pharmacokinetic studies on the mouse model revealed that cytarabine hydrochloride was still detectable after 24 h. Therefore, the cytarabine hydrochloride nanoparticles delivery system has a significant effect in the treatment of lymphoma.
Fig.2 In vitro release profiles of free cytarabine hydrochloride and cytarabine hydrochloride nanoparticles. (Ruckmani, et al., 2007)
With a professional analytical team, CD BioGlyco provides Pharmaceutical and Biological analysis services. Our analytical services have helped many of our clients solve problems promptly and drive their projects forward. Please feel free to contact us if you are interested in cytarabine hydrochloride for injection analysis.
Reference